ImmunoPrecise Antibodies Ltd (IPA)
1.12
-0.03
(-2.46%)
USD |
NASDAQ |
May 16, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
ImmunoPrecise Antibodies Revenue (Quarterly): 4.606M for Jan. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 4.606M |
| October 31, 2023 | 4.527M |
| July 31, 2023 | 4.259M |
| April 30, 2023 | 4.145M |
| January 31, 2023 | 3.834M |
| October 31, 2022 | 3.895M |
| July 31, 2022 | 3.640M |
| April 30, 2022 | 4.133M |
| January 31, 2022 | 3.800M |
| October 31, 2021 | 3.754M |
| July 31, 2021 | 3.734M |
| April 30, 2021 | 3.871M |
| January 31, 2021 | 3.508M |
| October 31, 2020 | 3.596M |
| July 31, 2020 | 2.752M |
| April 30, 2020 | 3.016M |
| January 31, 2020 | 3.065M |
| October 31, 2019 | 2.388M |
| July 31, 2019 | 2.045M |
| April 30, 2019 | 1.983M |
| January 31, 2019 | 2.023M |
| October 31, 2018 | 2.084M |
| July 31, 2018 | 2.202M |
| April 30, 2018 | 1.422M |
| January 31, 2018 | 1.362M |
| Date | Value |
|---|---|
| October 31, 2017 | 1.052M |
| July 31, 2017 | 0.4471M |
| April 30, 2017 | 0.4469M |
| January 31, 2017 | 0.383M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.045M
Minimum
Jul 2019
4.606M
Maximum
Jan 2024
3.609M
Average
3.754M
Median
Oct 2021
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.177M |
| Total Expenses (Quarterly) | 7.078M |
| EPS Diluted (Quarterly) | -0.0814 |
| Enterprise Value | 24.84M |
| Gross Profit Margin (Quarterly) | 51.39% |
| Profit Margin (Quarterly) | -47.26% |
| Earnings Yield | -37.03% |
| Normalized Earnings Yield | -36.89 |